Related Experiment Video
Updated: Jul 13, 2026
16:15
Mouse Kidney Transplantation: Models of Allograft Rejection
Published on: October 11, 2014
Chronic allograft nephropathy
Nidyanandh Vadivel1, Stefan G Tullius, Anil Chandraker
1Transplantation Research Center, Division of Nephrology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. nvadivel@rics.bwh.harvard.edu
Seminars in Nephrology
|July 10, 2007
Summary
Chronic allograft nephropathy (CAN) significantly impacts long-term kidney transplant survival, with rising re-transplant dialysis rates. Focusing on prevention is key to managing CAN and improving patient outcomes.
Area of Science:
- Nephrology
- Transplantation Immunology
- Immunosuppression
Background:
- Chronic allograft nephropathy (CAN) remains a major challenge in renal transplantation, limiting long-term graft survival despite advances in immunosuppression.
- One-year graft survival has improved, but long-term outcomes are stagnant, leading to a doubling of patients returning to dialysis in the last decade.
- Patients awaiting re-transplantation face increased mortality due to organ scarcity and heightened immunologic sensitization.
Purpose of the Study:
- To review the current literature on chronic allograft nephropathy (CAN).
- To discuss the definition, natural history, pathophysiology, and contributing factors of CAN.
- To explore potential novel therapeutic targets and emphasize prevention strategies for CAN.
Main Methods:
- Comprehensive analysis of the latest scientific literature on chronic allograft nephropathy.
- Detailed discussion of alloantigen-dependent and independent factors implicated in CAN.
- Identification and review of emerging therapeutic targets for CAN management.
Main Results:
- Long-term renal allograft survival has not significantly improved despite advances in immunosuppression.
- Factors contributing to CAN are complex, involving both immune and non-immune pathways.
- Early identification and proactive management are crucial for preventing CAN progression.
Conclusions:
- Prevention of CAN is paramount, shifting focus from cure to proactive management.
- Understanding the pathophysiology of CAN is essential for developing effective therapeutic strategies.
- Integrated management of contributing factors is vital for improving long-term renal allograft survival.
Related Concept Videos
01:25Chronic Kidney Disease I: Introduction
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
01:29Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
01:25Chronic Pancreatitis I: Introduction
Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...